Search Results 81-90 of 18216 for Hepatitis C

  1. Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C: Mayo Clinic Radio

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...

  2. Hepatitis C - Doctors and departments - Mayo Clinic

    Immunologists and virologists also are working on making a hepatitis C vaccine. Another area of research is cell transplant. This involves putting liver cells, ...

  3. Ribavirin (oral route) - Mayo Clinic

    For hepatitis C virus infection, in combination with interferon alfa-2b: For oral dosage form (capsules):. Adults—Dose is based on body weight and must be ...

  4. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus ...

  5. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  6. Mayo Clinic Radio: Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Listen to the program on Saturday, Aug ...

  7. A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C - Mayo Clinic

    ... liver transplant, are immune suppressed with Neoral or tacrolimus, and have a recurring infection with the Hepatitis C virus. Participation eligibility.

  8. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

    ... Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo ...

  9. Sofosbuvir, velpatasvir, and voxilaprevir (oral route) - Mayo Clinic

    Description. Sofosbuvir, velpatasvir, and voxilaprevir combination is used to treat chronic hepatitis C infection in adults (with or without cirrhosis) who ...

  10. Liver problems - Symptoms and causes - Mayo Clinic

    Hepatitis C. Immune system condition. Diseases in which the immune system attacks certain parts of the body are called autoimmune diseases. Autoimmune liver ...